AAAAAA
Results: 1-25/26
Authors:
Hirsch, FR
Prindiville, SA
Miller, Y
Franklin, WA
Dempsey, EC
Murphy, JR
Bunn, PA
Kennedy, TC
Citation: Fr. Hirsch et al., Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study, J NAT CANC, 93(18), 2001, pp. 1385-1391
Authors:
Stewart, JM
Gera, L
York, EJ
Chan, DC
Whalley, EJ
Bunn, PA
Vavrek, RJ
Citation: Jm. Stewart et al., Metabolism-resistant bradykinin antagonists: Development and applications, BIOL CHEM, 382(1), 2001, pp. 37-41
Authors:
Kelly, K
Lovato, L
Bunn, PA
Livingston, RB
Zangmeister, J
Taylor, SA
Roychowdhury, D
Crowley, JJ
Gandara, DR
Citation: K. Kelly et al., Cisplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in untreated patients with extensive-stage small cell lung cancer: A phase II trial of the southwest oncology group, CLIN CANC R, 7(8), 2001, pp. 2325-2329
Authors:
Bunn, PA
Helfrich, B
Soriano, AF
Franklin, WA
Varella-Garcia, M
Hirsch, FR
Baron, A
Zeng, C
Chan, DC
Citation: Pa. Bunn et al., Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents, CLIN CANC R, 7(10), 2001, pp. 3239-3250
Authors:
Hirsch, FR
Franklin, WA
Gazdar, AF
Bunn, PA
Citation: Fr. Hirsch et al., Early detection of lung cancer: Clinical perspectives of recent advances in biology and radiology, CLIN CANC R, 7(1), 2001, pp. 5-22
Authors:
Bunn, PA
Citation: Pa. Bunn, State-of-the art treatment of locally advanced and metastatic non-small cell lung cancer, ANTI-CANC D, 12, 2001, pp. S3-S8
Authors:
Bunn, PA
Citation: Pa. Bunn, Editorial comments on 'Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lungcancer patients: An EORTC double-blind placebo-controlled phase III study', ANN ONCOL, 12(10), 2001, pp. 1339-1340
Authors:
Bunn, PA
Citation: Pa. Bunn, Triplet combination chemotherapy and targeted therapy regimens, ONCOLOGY-NY, 15(3), 2001, pp. 26-32
Authors:
Kelly, K
Crowley, J
Bunn, PA
Presant, CA
Grevstad, PK
Mainpour, CM
Ramsey, SD
Wozniak, AJ
Weiss, GR
Moore, DF
Israel, VK
Livingston, RB
Gandara, DR
Citation: K. Kelly et al., Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-celllung cancer: A Southwest Oncology Group trial, J CL ONCOL, 19(13), 2001, pp. 3210-3218
Authors:
Kelly, K
Mikhaeel-Kamel, N
Pan, ZX
Murphy, J
Prindiville, S
Bunn, PA
Citation: K. Kelly et al., A phase I/II trial of paclitaxel, carboplatin, and gemcitabine in untreated patients with advanced non-small cell lung cancer, CLIN CANC R, 6(9), 2000, pp. 3474-3479
Authors:
Wood, ME
Kelly, K
Mullineaux, LG
Bunn, PA
Citation: Me. Wood et al., The inherited nature of lung cancer: a pilot study, LUNG CANC, 30(2), 2000, pp. 135-144
HER-2/neu as a therapeutic target in non-small cell lung cancer, prostate cancer, and ovarian cancer
Authors:
Agus, DB
Bunn, PA
Franklin, W
Garcia, M
Ozols, RF
Citation: Db. Agus et al., HER-2/neu as a therapeutic target in non-small cell lung cancer, prostate cancer, and ovarian cancer, SEMIN ONCOL, 27(6), 2000, pp. 53-63
Authors:
Pisters, KMW
Ginsberg, RJ
Giroux, DJ
Putnam, JB
Kris, MG
Johnson, DH
Roberts, JR
Mault, J
Crowley, JJ
Bunn, PA
Citation: Kmw. Pisters et al., Induction chemotherapy before surgery for early-stage lung cancer: A novelapproach, J THOR SURG, 119(3), 2000, pp. 429-437
Authors:
Bunn, PA
Citation: Pa. Bunn, Untitled - Introduction, CHEST, 117(4), 2000, pp. 71S-71S
Authors:
Bunn, PA
Mault, J
Kelly, K
Citation: Pa. Bunn et al., Adjuvant and neoadjuvant chemotherapy for non-small cell lung cancer - A time for reassessment?, CHEST, 117(4), 2000, pp. 119S-122S
Authors:
Bunn, PA
Kelly, K
Citation: Pa. Bunn et K. Kelly, New combinations in the treatment of lung cancer - A time for optimism, CHEST, 117(4), 2000, pp. 138S-143S
Authors:
Bunn, PA
Soriano, A
Johnson, G
Heasley, L
Citation: Pa. Bunn et al., New therapeutic strategies for lung cancer - Biology and molecular biologycome of age, CHEST, 117(4), 2000, pp. 163S-168S
Authors:
Kelly, K
Pan, ZX
Wood, ME
Murphy, J
Bunn, PA
Citation: K. Kelly et al., A phase I study of paclitaxel, etoposide, and cisplatin in extensive stagesmall cell lung cancer, CLIN CANC R, 5(11), 1999, pp. 3419-3424
Authors:
Bunn, PA
Citation: Pa. Bunn, Immune therapy for lung cancer - Are we getting closer?, AM J RESP C, 21(1), 1999, pp. 10-12
Authors:
Bunn, PA
Citation: Pa. Bunn, To treat or not to treat non-small-cell lung cancer patients? Current perspectives, ONCOLOGY-NY, 13(9), 1999, pp. 9-15
Authors:
Bunn, PA
Citation: Pa. Bunn, The emerging role of paclitaxel plus carboplatin in non-small-cell lung cancer, ONCOLOGY-NY, 13(9), 1999, pp. 35-41
Authors:
Bunn, PA
Kelly, K
Citation: Pa. Bunn et K. Kelly, Correspondence on brain metastases - Reply no. 2 to Letter by Dr Macbeth -# 98523; received 28 September 1998, LUNG CANC, 23(1), 1999, pp. 75-75
Authors:
Bunn, PA
Citation: Pa. Bunn, Triplet chemotherapy with gemcitabine, a platinum, and a third agent in the treatment of advanced non-small cell lung cancer, SEMIN ONCOL, 26(1), 1999, pp. 25-30
Authors:
Soriano, AF
Helfrich, B
Chan, DC
Heasley, LE
Bunn, PA
Chou, TC
Citation: Af. Soriano et al., Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell line, CANCER RES, 59(24), 1999, pp. 6178-6184
Authors:
Brown, J
Harken, AH
Rabinovitch, R
Soriano, AF
Bunn, PA
Citation: J. Brown et al., Lung cancer, BAS CLIN ON, 20, 1999, pp. 443-476